Chronic Obstructive Pulmonary Disease Clinical Trials

COPD Clinical Research Study

Compensation

Up to $1,900

For Completed Study

COPD Clinical research study

Diagnosed With Chronic Obstructive Pulmonary Disease?

Do you have Chronic Obstructive Pulmonary Disease (COPD) and want to help advance medical research? Join our clinical study to explore new treatment options while receiving care and compensation for your time.

By participating, you’ll be helping to improve the future of COPD therapies, all while contributing to groundbreaking research that could enhance the lives of millions. Find out if you qualify, learn about the study process, and see how you can make a difference in the fight against COPD. Sign up below to get started!

are you interested in our clinical trial?

COPD Study Eligibility

You could be eligible to participate in one of these research studies if you meet the following criteria:

Chronic Obstructive Pulmonary Disease Trial Eligibility Criteria

  • Ages 40-80

  • Diagnosed with COPD for at least 12 months

  • A COPD flare-up (exacerbation) in the past 12 months that was evaluated and documented by a physician in a clinic, urgent care, emergency department, or hospital

  • Currently using a double or triple maintenance inhaler therapy

  • At least 10 pack-year smoking history (former smokers must have quit at least 6 months ago)

two Convenient Tampa Bay locations

Study Locations

2147 NE Coachman Road
Clearwater, FL 33765
727-466-0078

605 N. Howard Ave.
Tampa, FL 33606
813-870-1292

Indication: Chronic Obstructive Pulmonary Disease (COPD)

What To Know About Volunteering For Our Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial

Participating in a clinical trial is completely voluntary, and you can choose to withdraw at any point. The process starts with identifying a trial that aligns with your needs, followed by consultations with study physicians to assess your eligibility. If you meet the criteria, you’ll sign an informed consent form, undergo any required screening tests, and then proceed with enrollment into the study.

Depending on the study, participation may last approximately 7 months or up to about 2 years. Study treatment may involve a daily tablet or injections approximately every 4 weeks. Participants are randomly assigned to receive an investigational treatment or placebo, which contains no active study medication.

Study visits may include breathing tests, physical examinations, blood and urine testing, heart monitoring, and health questionnaires. Some studies also require a daily electronic symptom diary. Participants continue their regular COPD medications as directed by the study team.

Clinical research COPD Study

Step 1:

Determine Eligibility

Fill out our online form to determine if you qualify for the COPD clinical trial.

COPD Trial

Step 2:

Participate In The Study

Study visits take place approximately every 4 weeks, over about 7 months or up to about 2 years depending on the study.

Chronic Obstructive Pulmonary Disease study

Step 3:

Compensation For Time/Travel

If qualified, study medication, visits, tests, and examinations are provided at no cost. Compensation of $100 or more is provided for each completed study visit, up to $1,900.

Why Participate in a Clinical Trial?

For individuals diagnosed with COPD, joining a clinical trial offers the chance to explore new treatment options designed to manage and reduce symptoms.

  • No Insurance Necessary: No insurance required for this treatment

  • Access to New Treatments: Get access to innovative treatments not yet available.

  • Personalized Care & Checkups: Receive specialized care tailored to your condition.
  • Contribution to Research: Help advance medical knowledge and new therapies.

  • Potential for Better Outcomes: Trial treatments may offer better results than current options.

Doctor in a white coat showing a tablet to a patient during a consultation

Official Registered Study

These clinical trials are officially registered with the U.S. National Library of Medicine. You can view full study details, including eligibility and locations, at ClinicalTrials.gov under study numbers NCT06496620, NCT06283966, and NCT06883305.

want to learn more?

What is COPD?

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition that makes it difficult to breathe. It typically includes two main conditions—chronic bronchitis and emphysema—both of which cause airflow blockage and long-term respiratory symptoms.

COPD is most commonly caused by long-term exposure to lung irritants, especially cigarette smoke. Other contributing factors may include air pollution, workplace dust or chemicals, and genetic conditions such as alpha-1 antitrypsin deficiency.

Common symptoms of COPD include:

  • Shortness of breath, especially during physical activity
  • Chronic cough with or without mucus
  • Wheezing
  • Chest tightness
  • Frequent respiratory infections
  • Fatigue

While COPD cannot be cured, early detection and proper treatment can slow disease progression, manage symptoms, and improve quality of life. COPD clinical research studies aim to find new therapies that can reduce exacerbations, improve lung function, and provide better daily symptom control.

More Detailed Information

Frequently Asked COPD Questions

COPD clinical trials improve treatment options by evaluating new medications, therapies, and interventions that may provide better symptom management and disease progression for individuals living with COPD.
Enrolling in a COPD clinical trial near you involves contacting Clinical Research of West Florida, providing your medical details, and verifying your eligibility based on the study criteria. Interested individuals can sign up to receive more information about available COPD trials and the enrollment process.

Participating in a COPD clinical trial can provide access to new treatments, expert medical care, and potential financial compensation up to $1,900, while also contributing to the advancement of lung disease research.

Current CRWF COPD studies enroll adults ages 40 to 80.

copd study questions

COPD Study Eligibility and Participation FAQs

To be eligible for a COPD clinical trial at Clinical Research of West Florida, participants must be ages 40 to 80, have been diagnosed with COPD for at least 12 months, have had a COPD flare-up (exacerbation) in the past 12 months that was evaluated and documented by a physician, be currently using a double or triple maintenance inhaler therapy, and have a smoking history of at least 10 pack years. Final eligibility is confirmed through a screening visit with the study team at either the Clearwater or Tampa facility.

Participants in the CRWF COPD clinical trial may receive up to $1,900 in compensation for their time and travel for completed study visits. If you qualify, study medication, visits, tests, and examinations are provided at no cost and no health insurance is required to participate.

Depending on the study, participation lasts approximately 7 months or up to about 2 years, with study visits about every 4 weeks. Participation is entirely voluntary, and participants may withdraw at any time.

A pack year equals smoking one pack of cigarettes per day for one year. A 10 pack-year history could mean smoking one pack daily for 10 years, two packs daily for 5 years, or any equivalent combination. This threshold matters because COPD is most commonly caused by long-term exposure to lung irritants, especially cigarette smoke, and the current CRWF COPD studies require a smoking history of at least 10 pack years, and former smokers must have quit at least 6 months before joining.

Yes. These COPD clinical trials are officially registered with the U.S. National Library of Medicine on ClinicalTrials.gov under study numbers NCT06496620, NCT06283966, and NCT06883305. You can view full study details, including eligibility and locations, on the ClinicalTrials.gov website.

Interested In Learning More

Enroll Now